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ABSTRACT 
Linga Chendhuram (LC) is a herbo-mineral formulation cited in Siddha literature Siddha Vaithiya Thirattu 
comprises of purified Lingam (Cinnabar) processed in herbal juice – Citrullus colocynthis and used in the 
management of various types of fever, arthritis and anaemia at 65 mg/dose. Acute and Sub-acute oral 
toxicity of Linga Chendhuram was carried out in Wistar rats under OECD guidelines 423 and 407. In acute 
study, LC was administered at 2000mg/kg orally and animals were observed for toxic signs for 14 days. In 
sub-acute toxicity study, test groups were treated with LC at 18, 90 and 180 mg/kg/day along with 2 ml of 
diluted honey and control group with distilled water 2 ml/day for 28 days daily. LC at 2000mg/kg 
produced no treatment related toxic signs or mortality during the study. Haematological and biochemical 
parameters were analyzed using auto analyzer with standard kits and one way ANOVA followed by 
Dunnett test was performed for significant analyses. Gross necropsy and histopathology studies using H&E 
stain were done on major organs. LD50 was found more than 2 g/kg. No-Observed-Adverse-Effect level of 
LC was seen at 180 mg/kg in 28 days of treatment. No abnormal findings were noted in high dose group 
organs. Administration of LC at its human therapeutic dose of 195 mg/kg in rat (180 mg/kg) is safe. 
KEYWORDS: Siddha, Linga Chendhuram, Acute oral toxicity, Sub-acute toxicity. 
INTRODUCTION 
 Siddha system is one among the Indian systems of 
Medicine has been practicing in Tamil speaking part of 
world. Initially, it is practiced in a Guru-Shisya Parampara, 
now has been institutionalized. This system was founded 
by ‘Siddhars’ who are known for their versatile abilities. 
They were the masters in natural chemistry and 
formulated medicinal preparations uti1lizing various 
natural resources such as plants, minerals, metals (forms 
of metals and metalloids derived from the elemental form) 
and animals. Purified form of Mercury and Sulphur plays a 
vital role in the formulation of Siddha drugs used for the 
treatment of chronic and auto immune diseases. Lingam is 
a mercuric compound, chemically red sulphide of mercury 
having specific gravity 8.1. This sulphide occurs in nature 
as a fine grained, dark red, very heavy mineral ore called 
cinnabar. This compound is entirely different from Kajjali. 
Kajjali is a black sulphide compound prepared artificially 
by grinding equal parts of mercury and sulphur till the 
globules disappear. But Lingam is a naturally occurring red 
sulpide compound and having different properties besides 
Kajjali. This is the most stable form than black form. 
Cinnabar contains 96% HgS, and Hg is a highly toxic heavy 
metal. The different chemical forms (organic and 
inorganic) of mercurial compounds exhibit different 
degrees of toxicity with effects including hearing loss, 
vision disturbance, motor deficits, and retarded or 
abnormal walking ability [1,2]. Despites its toxicity, cinnabar 
has traditionally been used in Indian system of medicine. 
Drugs having these heavy metals more than their 
allowable limits are banned in many countries. JAMA 
published an article reporting that the presence of heavy 
metals such as Lead, Cadmium, Arsenic and Mercury over 
the permissible limit of WHO in Ayurvedic drugs [3]. Based 
on that, the western countries bans the traditional drugs in 
the market, after that Department of AYUSH, Govt. of India 
made valuable effort in overcoming this issue and strongly 
incised to do characterization and toxicological studies in 
experimental animals for proving the safety of the 
traditional drugs. Lingam based preparation is effective in 
the treatment of diarrhea, pyrexia, delirium, urticaria, 
dieresis, tuberculosis, scabies, unknown insect bites, 
syphilis, leprosy, eczema, skin diseases, throbbing pain 
(Soolai) and Vatha diseases. Lingam involves as an 
ingredients in various preparation such as Linga 
chendhuram, Padigalinga thuvar, Jathi Jambeera kuzhambu, 
Brammanandha bairavam, Vasantha kusumagaram, etc [4]. 
Arun Sudha et al., (2009) has been reported that Linga 
chendhuram has the presence of nano particles in the 
range of 40 -50 nm [5]. EDAX, XRD and TGA showed the 
presence of HgS as the main constituent under the 
permissible limit. ICP-OES analysis has shown the 
presence of Ca, Cd, Cr, Cu, Fe and Mg in below 1% of Linga 
chendhuram. The toxicological level of Linga chendhuram 
is not found yet. In view of this issue, we validated the 
safety of Linga chendhuram in animal model.  
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MATERIALS AND METHODS 
Preparation of Linga Chendhuram 
 Linga Chendhuram (LC) was prepared by the 
method described in Siddha Vaithiya Thirattu[6]. The raw 
materials used in the preparation were Lingam (Cinnabar) 
and entire herb Atruthumatti (Citrullus colocynthis). The 
raw lingam was procured from registered Siddha Medical 
practitioner Dr. Murugesan MD Siddha, Orathanadu, 
Tamilnadu. The Lingam got authentication from Dr. M. 
Suresh Gandhi, Assistant professor, Department of 
Geology, Madras University. The plant material 
Atruthumatti was collected from herbal garden of National 
Institute of Siddha, Chennai and got authentication from 
the botanist (Specimen Voucher No. NIS/MB/97/2013) of 
National Institute of Siddha, Chennai. Before the actual 
preparation process, the lingam was purified by Surukku 
method done as per Gunapaadam Thathu & Jeeva Vaguppu 
[4]. LC was prepared in Gunapadam (Siddha pharmacology) 
lab of National Institute of Siddha, Chennai, India, 
following standard procedures mentioned in the literature. 
The purified Lingam is placed in a new open mud pan and 
subject to heat. Then, the juice of Atruthumatti samulam is 
added drop by drop over the Lingam to fuse until addition 
of entire juice. After this process, Lingam is taken to 
‘Kalvam’ (a traditional grinding tool made of black stone) 
and ground it into fine powder. This finished red colour 
formulation will be stored in an appropriate vessel. 
Experiment animal’s husbandry 
 The study protocol has got approval from 
Institutional Animal Ethical Committee of National 
Institute of Siddha, Chennai (1248/ac/09/CPCSEA/5-
12/2011). Male and female Wistar Albino rats (8–12weeks 
and males; 120–160g; females: 120–160g) were obtained 
from the animal house of King Institute of Preventive 
Medicine, Guindy, Chennai and maintained in the animal 
house of National Institute Siddha, Chennai. Animals were 
housed in individually in polypropylene cages in a 
ventilated room (air cycles: 15/min; 70:30 exchange ratio) 
under an ambient temperature of 22±2°C and 40–65% 
relative humidity, with a 12-h light/dark artificial 
photoperiod. The animals received RO water ad libitum 
and fed with Amruth Rodent pellet.  
Acute oral toxicity study 
 This study was carried out by following the 
procedure with the starting dose of 2000 mg/kg body 
weight of test drug mentioned in OECD 423 guideline [7, 8]. 
Six female rats were randomly selected and acclimatized 
prior to the study. Each selected animal was kept in 
separate poly propylene cage and marked with picric acid 
on the fur for identification. The rats were fasted overnight 
before the administering of test drug. After the 
administration of test drug, the rats were deprived of feed 
for 16 h and water was not allowed for initial 3 h. Initially, 
the starting dose 2000 mg/kg of LC was chosen and 
administered to three rats and observed for mortality and 
clinical signs of toxicity (General behaviour, respiratory 
pattern, cardiovascular signs, motor activities, reflexes and 
changes in skin and fur texture) at 30 min, 1, 2 and 4 hours 
and thereafter once a day for the next 14 days. Since there 
was no mortality and abnormal signs, further three 
animals were administered with LC at the same dosage of 
2000 mg/kg and observed for mortality and clinical signs 
of toxicity. LD50 cut-off value of LC was determined in 
accordance with Globally Harmonized System of 
Classification and Labeling of chemicals.  
Sub-acute oral toxicity study 
 This study was carried out by following OECD 
guidelines [9]; adopted for the testing of chemicals – 407 
(3rd October, 2008) and was modified according to the 
experimental need. In the literature Siddha Vaithiya 
Thirattu, the human intended dosage for LC was 
recommended as 65 mg three times a day (195 mg/day). 
On the basis of body surface area conversion against 
human dose, 18 mg/kg/day dosage of LC was calculated 
for rat. In the present study, three doses of LC of 18 
mg/kg/day (Low dose), 90 mg/kg/day (Intermittent dose) 
and 180 mg/kg/day (High dose) were selected for 
administration. 
 The both sexes of Wistar Albino rats were 
randomized into four groups of ten animals each (5 males, 
5 females). Group I received a vehicle (Honey 1ml + 
distilled water 1ml) and served as control group. Group II, 
III and IV served as low, intermittent and high doses of LC 
respectively. All the test substances were administered 
once daily via oral route through gastric lavage for 28 days.  
 All the experimental animals were observed for 
mortality and morbidity twice a day, till the completion of 
treatment. Clinical observations were made once daily to 
detect signs of toxicity, preferably at the same time(s) in 
each day (1h after vehicle or LC administration). The focus 
of the observations was the same as described above for 
the acute toxicity study. Body weights of the animals were 
recorded once in a week. The amounts of food and water 
given and their remnants on the next day were measured 
to calculate the difference, which was regarded as daily 
consumption and the data were expressed as 7 days 
cumulative value. At the end of 28th day treatment, live rats 
were fasted over night and on 29th day under light 
chloroform anaesthesia blood were drawn from the retro 
orbital sinus in a potassium tube EDTA and a tube without 
anti coagulant. 
Haematological and biochemical parameters 
 The haematological parameter tests such as 
Haemoglobin (Hb), Red Blood Cell count (RBC), White 
Blood Cell count (WBC), WBC Differential count - 
Lymphocyte, Monocyte and Granulocyte, Red Cell 
Distribution Width (RDW), Haematocrit (HCT), Mean 
Corpuscular Volume (MCV), Mean Corpuscular 
Haemoglobin (MCH), Mean Corpuscular Hemoglobin 
Concentration (MCHC), Platelet (Plt), Platelet Crit (PCT), 
Platelet Distribution Width (PDW) and Mean Platelet 
Volume (MPV) were done in the EDTA mixed blood 
samples using Erba Mannhein® haematology analyser. 
The blood samples without anticoagulant were used for 
estimating biochemical parameters such as Glucose, 
Cholesterol, Triglyceride (TG), Protein, Urea, Creatinine, 
Bilirubin, Serum glutamic-oxaloacetic transaminase 
(SGOT), Serum glutamic pyruvic transaminase (SGPT) and 
Alkaline Phosphatase (ALP) using Erba system Pack kits in 
Fully Automated Biochemistry analyzer. Sodium, 
Potassium and Chloride content were estimated by using 
electrolyte analyser from Roche®.  
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Necropsy and Histo-pathological study 
 After withdrawal of blood, all the rats were 
sacrificed for gross necropsy and histopathological study. 
Organs including brain, trachea, lungs, heart, liver, kidney, 
stomach, spleen, intestine, testis, seminal vesicle, bladder, 
uterus and ovaries were studied for gross necropsy and 
weighed for calculating relative organ weight. 
Histopathological studies on liver, kidney, lungs, stomach, 
heart, spleen, brain, and femorotibial joints were carried 
out for control and high dose group. The tissues of 
collected organs were fixed in 10% Neutral buffered 
formalin for 24 h. The tissues were trimmed, embedded in 
molten paraffin wax and sectioned (4-5 microns thickness) 
using rotary microtome. The sections were floated in hot 
water and placed in the glass slide. The slides were stained 
with Haematoxylin and Eosin (H&E), mounted in DPX and 
examined under light microscope. 
Statistical analysis 
 All data were expressed as mean ± standard 
deviation (SD). The test groups were compared with 
control for testing significance by one way ANOVA 
followed by Dunnet test using GRAPH PAD INSTAT version 
3 software programmes. Values of p<0.05 were considered 
significant. 
RESULTS 
Acute oral toxicity study 
 The acute toxicity study showed no mortality of 
rats up to the dosage of 2000mg/kg. No behavioural 
changes or abnormal clinical signs of toxicity were 
observed up to the above dosage throughout the end of 14 
day study period. No gross pathological abnormality in the 
organs was found even at this high dose. LD50 value was 
found to be more than 2000 mg/kg body weight and 
therefore this test drug Linga chendhuram falls under 
(Unclassified) category V with reference to Globally 
Harmonized classification System (GHS) (OECD, 2000).  
Sub-acute oral toxicity study  
 For a period of 28 consecutive days of oral 
treatment of LC at 18, 90 & 180mg/kg/day in both sexes of 
rat, no treatment related toxicity signs or mortality were 
observed. Feed and water consumption of treated groups 
were found not to be significantly affected or changed in 
both sexes compared to the vehicle treated rats. But no 
significant change in the body weight gained or lost in the 
treated test groups were observed compared with control 
group during the study (Table I & II). The absolute and 
relative organs weight was also not altered by LC 
treatments (Table III & IV). If LC were a toxic substance, 
there would have been a minimal reduction in body weight 
gain and internal organs weight. 
Table 1: Effect of Linga chendhuram on body weight gained in male wistar albino rats - 28 day repeated oral 
toxicity study 
Treatment Initial day (g) On7th day (g) On14th day(g) On 21th day (g) On 28th day (g) 
Control 
(Honey2ml) 
146.28±4.32 152.36±8.68 168.46±10.46 180.74±12.14 184.42±08.14 
18 mg/kg 148.46±9.24 156.4±8.28 170.2±11.67 181.4±15.2 190.8±10.46 
90 mg/kg 136.46±11.22 143.4±14.32 161.8±16.2 168.6±16.24 176.24±14.38 
180 mg/kg 139.16±8.67 144.02±10.84 162.46±11.26 178.64±16.43 184.2±12.46 
Values are expressed as mean ± S.D. (n = 5) 
Table 2: Effect of Linga chendhuram on body weight gained in female wistar albino rats - 28 day repeated oral 
toxicity study 
Treatment Initial day (g) On7th day (g) On14thday (g) On21th day (g) On28th day(g) 
Control 
(Honey2ml) 
148.46±11.32 153.6±12.38 158.6±10.12 164.6±8.64 168.8±8.32 
18 mg/kg 144.24±14.14 152±6.3 158.4±11.62 162±5.64 169.6±6.32 
90 mg/kg 136.46±2.14 142.6±8.24 150.6±11.58 158.64±10.26 164.6±16.42 
180 mg/kg 142.46±4.92 146.6±6.24 151.7±8.42 159.4±11.64 163.72±8.96 
Values are expressed as mean ± S.D. (n = 5) 







18 mg/kg 90 mg/kg 180 mg/kg 
Brain 0.97±0.13 0.95±0.06 1.04±0.09 0.96±0.04 
Heart 0.39±0.05 0.41±0.01 0.39±0.03 0.36±0.04 
Liver 3.46±0.24 3.70±0.14 3.84±0.42 3.59±0.32 
Spleen 0.45±0.03 0.51±0.07 0.41±0.06 0.45±0.03 
Kidney 0.86±0.04 0.91±0.05 0.92±0.12 0.84±0.04 
Testis 1.04±0.09 1.10±0.11 1.08±0.08 1.06±0.12 
Values are expressed as mean ± S.D. (n = 5) 
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18 mg/kg 90 mg/kg 180 mg/kg 
Brain 1.03±0.02 1.05±0.05 1.06±0.04 1.08±0.02 
Heart 0.42±0.03 0.42±0.02 0.40±0.03 0.40±0.01 
Liver 4.01±0.32 4.10±0.19 4.25±0.02 4.08±0.16 
Spleen 0.46±0.03 0.44±0.03 0.43±0.03 0.42±0.04 
Kidney 0.76±0.08 0.80±0.02 0.72±0.02 0.82±0.02 
Testis 0.08±0.02 0.07±0.02 0.07±0.02 0.06±0.01 
Values are expressed as mean ± S.D. (n = 5)
Among haematological parameters analyzed in male rats, MCH (pg) and MCHC (g/dl) level was significantly reduced in test 
groups at three dose levels on compared with control group. Among hematological parameters analyzed in female rats, 
Monocyte(109/L) was significantly reduced in 90mg/kg LC treated group, Haemoglobin (g/dL), Total RBC (1012/L), RDW 
(%), Hematocrit (%) and Platelet crit (%) values were significantly increased in 18mg/kg of LC on compared with control 
group. Among biochemical parameters analyzed in male rats, Urea (mg/dl), Creatinine (mg/dl) and ALP (U/L) was 
significantly reduced and Bilirubin (mg/dl) was significantly increased in 18mg/kg of LC on compared with control group. 
The haematological and biochemical parameters show no significant different between the test groups on compared with 
control group. 
Table 5: Effect of Linga chendhuram on hematological parameters in male Wistar albino rats - 28 day repeated 
oral toxicity study 
Parameter Control 
 (Honey 2ml) 
Linga chendhuram 
18 mg/kg 90 mg/kg 180 mg/kg 
Total WBC (109/L) 9.6±2.01 11.24±2.93 10.24±3.58 8.74±1.46 
Lymphocyte (109/L) 5.06±0.79 7.2±2.59 5.6±2.43 5.68±1.76 
Monocyte (109/L) 0.3±0.12 0.34±0.09 0.24±0.05 0.26±0.05 
Granulocyte (109/L) 3.62±0.80 3.68±0.61 4.34±2.89 3.78±1.08 
Hemoglobin (g/dL 17.5±2.79 18.32±1.99 13.04±2.29 13.72±3.76 
Total RBC (1012/L) 9.89±1.51 10.57±0.77 7.71±1.32 8.3±2.12 
RDW (%) 11.4±1.24 11.4±0.83 10.94±0.53 11.1±0.33 
Hematocrit (%) 51.7±8.50 47.16±18.50 39.94±6.93 42.4±11.70 
MCV (fL) 52.36±0.89 51±1.10 51.84±0.507 50.94±1.23 
MCH (pg) 17.6±0.46 16.6±0.58** 16.84±0.28* 16.3±0.26** 
MCHC (g/dL) 33.8±0.60 32.62±0.64* 32.58±0.56* 32.12±0.47** 
Platelet (109/L) 96.4±33.5 136.4±60.69 151.8±65.50 153.6±65.05 
Platelet crit (%) 0.05±0.02 0.08±0.35 0.08±0.37 0.09±0.03* 
PDW (%) 15.3±0.19 15.2±0.25 15.28±0.37 15.16±0.15 
MPV(fL) 6.16±0.19 6.0±0.15 5.92±0.21 6.06±0.11 
WBC: White blood count; RBC: Red blood cell; RDW: Red cell distribution width; MCV: mean corpuscular volume; MCH: 
mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; PDW: Platelet distribution width; 
MPV: Mean platelet volume  
Values are expressed as mean ± S.D. (n = 5). P value calculated using one way ANOVA followed by Dunnett test. 
Significance is indicated as *p < 0.05 vs control group. 
Table 6: Effect of Linga chendhuram on hematological parameters in female wistar albino rats - 28 day repeated 




18 mg/kg 90 mg/kg 180 mg/kg 
Total WBC (109/L) 7.34±2.94 9.8±1.69 8.18±0.5 7.2±1.8 
Lymphocyte (109/L) 4.08±1.56 4.78±0.84  4.28±0.16 3.98±1.59 
Monocyte (109/L) 0.28±0.14 0.24±0.05 0.14±0.05* 0.22±0.04 
Granulocyte (109/L) 3.6±2.2 3.28±0.56 2.26±0.47 2.36±0.78 
Hemoglobin (g/dL) 13.9±4.13 19.8±0.89** 17.9±2.54 17.42±1.04 
Total RBC (1012/L) 7.99±2.18 11.81±0.52** 10.8±1.4* 10.42±0.79* 
RDW (%) 10.02±0.8 11.4±0.83* 10.94±0.53 11.1±0.33* 
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Hematocrit (%) 42.5±13.7 60.34±2.14** 51.38±7.18 45.1±3.24  
MCV (fL) 52.6±3.28 51.16±1.04 53.68±0.62 52.8±0.95 
MCH (pg) 17.3±0.62 16.6±0.58 16.84±0.28 16.3±0.26** 
MCHC (g/dL) 33.08±1.2 32.62±0.64 32.52±0.76 33.5±0.66 
Platelet (109/L) 83.4±18.6 157.2±30.43** 173.0±46.92** 134.0±30.43 
Platelet crit (%) 0.05±0.0 0.1±0.02** 0.11±0.03** 0.08±0.02 
PDW (%) 15.42±0.43 15.26±0.18 15.34±0.32 15.24±0.15 
MPV(fL) 6.22±0.36 6.42±0.22 6.08±0.23 6.04±0.25 
WBC: White blood count; RBC: Red blood cell; RDW: Red cell distribution width; MCV: mean corpuscular volume; MCH: 
mean corpuscular hemoglobin; MCHC: mean corpuscular hemoglobin concentration; PDW: Platelet distribution width; 
MPV: Mean platelet volume  
Values are expressed as mean ± S.D. (n = 5). P value calculated using one way ANOVA followed by Dunnett test. 
Significance is indicated as *p < 0.05 vs control group 





18 mg/kg 90 mg/kg 180 mg/kg 
Glucose (mg/dl) 72.6±11.71 77.2±9.5 83.2±11.7 72.6±12.2 
Cholesterol (mg/dl) 70.0±9.4 83.8±6.04 77.2±6.97 81.4±10.18 
Triglyceride (U/L) 82.6±16.31 91.2±9.4 84.2±5.82 95.8±5.94 
Protein (g/dL) 6.8±0.08 7.2±0.56 7.18±0.71 7.2±0.81 
Urea (mg/dl) 42.8±1.92 32.2±4.86* 35.2±5.8  42.6±7.43  
Creatinine (mg/dl) 1.18±0.13 0.9±0.2* 0.92±0.14* 1.02±0.13 
Bilirubin (mg/dl) 0.38±0.08 0.62±0.16* 0.48±0.16 0.48±0.08  
SGOT (U/L) 201.4±43.52 177.2±17.93 184±37.23 174.2±35.94 
SGPT (U/L) 86.4±20.0 75.4±13.63 72.0±13.78 55.0±9.24* 
ALP(U/L) 429.8±36.8 293.8±35.92* 277.0±83.13** 375.2±83.67 
Sodium (mmol/L) 144.0±5.43 140.2±7.69 137.3±16.21 142.3±10.01 
Potassium (mmol/L) 4.6±1.3 4.81±2.32 4.01±1.21 4.9±1.20 
Chloride (mmol/L) 104.6±4.22 112.4±10.9 107.7±8.01 112.1±10.42 
SGOT: Serum Glutamic Oxaloacetic Transaminase; SGPT: Serum Glutamic Pyruvic transaminase; ALP: Alkaline 
Phosphatase 
Values are expressed as mean ± S.D. (n = 5). P value calculated using one way ANOVA followed by Dunnett test. 
Significance is indicated as *p < 0.05 vs control group 







18 mg/kg 90 mg/kg 180 mg/kg 
Glucose (mg/dl) 79.6±7.43 83.8±11.4 94.4±17.7 97.0±17.6 
Urea (mg/dl) 35.0±12.64 39.6±4.97 40.0±5.14 40.6±7.63 
Creatinine (mg/dl) 0.86±0.11 0.72±0.08 0.8±0.0 0.84±0.13 
Cholesterol (mg/dl) 70.0±9.4 76.0±14.31 65.0±8.27 70.8±25.8 
Triglyceride (U/L) 177.6±32.3 179.8±54.96 215.8±42.28 188.4±76.33 
SGOT (U/L) 129.4±34.93 155.0±31.21 135.6±26.81 151.8±30.54 
SGPT (U/L) 50.8±17.76 47.8±8.58 54.8±13.06 52.0±10.14 
ALP (U/L) 310.6±52.07 285.0±59.66 304.8±39.01 307.2±40.59 
Bilirubin (mg/dl) 0.76±0.09 0.62±0.16 0.6±0.07 0.7±0.10 
Sodium (mmol/L) 145.0±6.31 140.2±8.1 137.3±16.78 143.8±11.54 
Potassium(mmol/L) 4.4±1.2 5.38±2.68 4.26±1.34 4.8±1.02 
Chloride (mmol/L) 105.9±4.86 113.4±11.89 106.8±7.55 111.6±10.49 
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SGOT: Serum Glutamic Oxaloacetic Transaminase; SGPT: Serum Glutamic Pyruvic transaminase; ALP: Alkaline 
Phosphatase 
 Values are expressed as mean ± S.D. (n = 5). P 
value calculated using one way ANOVA followed by 
Dunnett test. Significance is indicated as *p < 0.05 vs 
control group 
 The gross necropsy study on the organs revealed 
no abnormal pathological morphology. H&E stained kidney 
slices of female rats of high dose group showed changes in 
their architecture by the presence of minimal infiltration of 
mononuclear cells indicated slight inflammation of 
glomeruli (Figure 1C, 1D). But in the kidney of male rats, 
no evidence of such lesions was observed (Figure 1B). No 
abnormal changes were observed in other H&E stained 
slices of organs and they were not shown in the figure.  
DISCUSSION 
 Linga Chendhuram (LC) is a Sastric Siddha 
formulation prepared using purified Lingam (Cinnabar) by 
triturating with the juice of Citrullus collocynthis. LC was 
used for long period in the therapeutic management of 
fevers, arthritis and anemia. Cinnabar (Mercury sulphide) 
did not produce much toxicity rather than other mercurial 
compounds since its poor absorption in GI tract [10]; 
However many studies reported that on chronic 
administration of Cinnabar produce severe toxic effects. 
While using toxic substance in the preparation of Siddha 
Formulation, it is mandatory to do the special purification 
process. On using Lingam, if it is not properly purified and 
the process of Lingam based formulation is incomplete, it 
will result in toxicity such as inflammation of alimentary 
canal, urinary disorders, neurological effects, burning 
sensation of all over the body, etc. This study tested the 
acute and sub acute toxicity of LC to substantiate its safety 
for human use. LC was orally administered at higher dose 
2 gm/kg to the Wistar Albino rats in acute toxicity study 
and for 28 days of repeated (sub acute) toxicity study daily 
doses of 18, 90 & 180 mg/kg of body weight to the Wistar 
Albino rats. The median lethal dose for LC in rat was 
estimated more than 2000 mg/kg and this dose was 100 
times more than that of the human therapeutic dose. It was 
clearly proved that the human therapeutic dose was 
absolutely free from acute toxicity. After completing sub 
acute oral toxicity study on LC at three dose levels 18, 90 & 
180mg/kg/day, no fatal and abnormal signs happened in 
the rats. If any toxic substance is consumed for the above 
period, there will be change in the body weight due to 
altered metabolism. During the period, no significant 
reduction in the body and organ weight was observed 
revealed that LC does not much interfere in the 
metabolism.  
 From the results of present investigation on 
haematological and biochemical parameters, we observed 
some variations among the male and female rats. In male 
rats treated with test drug observed that MCH, MCHC, 
Urea, Creatinine and ALP levels were significantly reduced 
but bilirubin was significantly increased. But in female 
rats, no significant difference was observed on these levels. 
In female rats, Hb, RBC, RDW, Hct, and Platelet crit levels 
were significantly increased but monocyte level was 
significantly reduced. These changes were not noted in 
male rats. All the haematological and biochemical 
parameters were within the normal limits in both male 
and female rats treated with LC at different dosages. The 
variations seen in the above said parameters were not 
much critical in establishing pathological lesions since 
differences observed were statistically on compared with 
control groups. If the drug is toxic, there will be reduction 
in Hb content, RBC count and Hct value and indicate the 
shortfall in Iron metabolism leading to disturbance in 
Erythropoiesis. Such condition seen in Anaemic condition. 
Here, LC does not interfere in the haematological 
parameters. Liver and Kidney plays a significant role in 
eliminating toxins or foreign materials. If these organs are 
damaged, it will result increased excretion of hepatic 
enzymes and protein, urea, and creatinine in the blood. All 
biochemical parameters investigated were within the 
normal limits in the test group’s favors LC did not cause 
damage to the heart, liver, kidney and other organs. If 
there is any damage occurs, it will reflect in the gross and 
histological appearance of the sliced organs. No observable 
pathological findings were found in the organs of LC high 
dosed group confirmed that it is a safer drug. 
CONCLUSION 
 Linga Chendhuram is a Siddha Sastric formulation 
prepared by processing purified Cinnabar with herbal 
juice of Citrullus colocynthis and having therapeutic value 
against fever with arthralgia at 65 mg/dose. To establish 
the safety profile of this formulation, acute and sub acute 
toxicity studies in Wistar albino rats were done following 
OECD guideline 423 and 407 respectively. The median 
lethal dose for Linga Chendhuram was found more than 2 
g/kg. No-Observed-Adverse-Effect level of LC was seen at 
180 mg/kg in 28 days of treatment. No abnormal findings 
were noted in high dose group organs. Under this study, it 
is concluded that Linga Chendhuram at its human 
therapeutic dose 195 mg/kg is safer in rat model. 
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Fig.1: A - H&E sliced kidney of control group showing normal architecture (10X) 
B - H&E sliced kidney of test group of male rat treated with LC at 180 mg/kg       showing normal architecture (10X) 
C - H&E sliced kidney of test group of female rat treated with LC at 180 mg/kg       showing infiltration of 
mononuclear cells (10X) 
D - H&E sliced kidney of test group of female rat treated with LC at 180 mg/kg       showing infiltration of 
mononuclear cells (40X) 
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